CA2437114A1 - Diamides which inhibit tryptase and factor xa activity - Google Patents

Diamides which inhibit tryptase and factor xa activity Download PDF

Info

Publication number
CA2437114A1
CA2437114A1 CA002437114A CA2437114A CA2437114A1 CA 2437114 A1 CA2437114 A1 CA 2437114A1 CA 002437114 A CA002437114 A CA 002437114A CA 2437114 A CA2437114 A CA 2437114A CA 2437114 A1 CA2437114 A1 CA 2437114A1
Authority
CA
Canada
Prior art keywords
group
aryl
alkyl
aralkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002437114A
Other languages
English (en)
French (fr)
Inventor
Sven Nerdinger
Thilo Fuchs
Katrin Illgen
Robert Eckl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morphochem GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2437114A1 publication Critical patent/CA2437114A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Indole Compounds (AREA)
CA002437114A 2001-02-23 2002-02-22 Diamides which inhibit tryptase and factor xa activity Abandoned CA2437114A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP01103662.1 2001-02-23
EP01103662 2001-02-23
EP01116782.2 2001-07-20
EP01116782 2001-07-20
PCT/EP2002/001934 WO2002068390A1 (en) 2001-02-23 2002-02-22 Diamides which inhibit tryptase and factor xa activity

Publications (1)

Publication Number Publication Date
CA2437114A1 true CA2437114A1 (en) 2002-09-06

Family

ID=26076479

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002437114A Abandoned CA2437114A1 (en) 2001-02-23 2002-02-22 Diamides which inhibit tryptase and factor xa activity

Country Status (12)

Country Link
US (1) US7256194B2 (enExample)
EP (1) EP1370526B1 (enExample)
JP (1) JP2004523560A (enExample)
AT (1) ATE327221T1 (enExample)
AU (1) AU2002254907A1 (enExample)
CA (1) CA2437114A1 (enExample)
CY (1) CY1105506T1 (enExample)
DE (1) DE60211665T2 (enExample)
DK (1) DK1370526T3 (enExample)
ES (1) ES2260428T3 (enExample)
PT (1) PT1370526E (enExample)
WO (1) WO2002068390A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893437A4 (en) * 1996-04-10 2000-12-27 Ono Pharmaceutical Co GUANIDINO TRYPTASE INHIBITOR
SI0921116T1 (en) * 1997-12-04 2003-10-31 F. Hoffmann - La Roche Ag N-(4-carbamimido-phenyl)-glycine amide derivatives
DE19939910A1 (de) * 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
DE10041402A1 (de) * 2000-08-23 2002-03-14 Morphochem Ag Neue Verbindungen, die Faktor Xa-Aktivität inhibieren

Also Published As

Publication number Publication date
EP1370526B1 (en) 2006-05-24
PT1370526E (pt) 2006-08-31
WO2002068390A8 (en) 2002-10-31
ES2260428T3 (es) 2006-11-01
DE60211665D1 (de) 2006-06-29
DE60211665T2 (de) 2006-09-28
WO2002068390A1 (en) 2002-09-06
AU2002254907A1 (en) 2002-09-12
US7256194B2 (en) 2007-08-14
JP2004523560A (ja) 2004-08-05
US20040082547A1 (en) 2004-04-29
EP1370526A1 (en) 2003-12-17
ATE327221T1 (de) 2006-06-15
CY1105506T1 (el) 2010-04-28
DK1370526T3 (da) 2006-07-31

Similar Documents

Publication Publication Date Title
RU2125991C1 (ru) Карбоксамиды, их гидраты или сольваты и физиологически совместимые соли
KR100218600B1 (ko) 구아니딘
HU206192B (en) Process for producing benzoic acid and phenylacetic acid derivatives and pharmaceutical compositions comprising such active ingredient
SK282995B6 (sk) Zlúčenina na inhibíciu metaloproteázy a prostriedok s jej obsahom
JPH04217652A (ja) 酢酸誘導体、その製造法、それを含む製薬調製剤、及びその製薬調製剤製造への利用
WO1999017790A1 (en) PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
NO312550B1 (no) Piperazinderivater, fremgangsmåte for fremstilling derav, farmasöytiske preparater, fremgangsmåte for fremstilling derav,samt anvendelse av forbindelsene for fremstilling av et legemiddel
CA2294113A1 (en) Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical preparations containing these compounds
AU744567B2 (en) Biphenylamidine derivatives
HUP0301670A2 (hu) Xa faktor aktivitását gátló vegyületek, azokat tartalmazó gyógyászati készítmények és alkalmazásuk
JP4384277B2 (ja) 置換された６−および７−アミノテトラヒドロイソキノリンカルボン酸
US20050228017A1 (en) Novel anticancer compounds
AU6572900A (en) Compounds that inhibit tryptase activity
JPH04217950A (ja) ヒドロキサム酸誘導体および酵素阻害剤ならびに抗潰瘍剤
CA2342985C (en) Hydroxamate-containing cysteine and serine protease inhibitors
WO2000058304A1 (en) Heterocyclic sulfonamide derivatives
KR20010102140A (ko) 콜린작용 활성을 강화시키기 위한 아미드 화합물
US20030130325A1 (en) Substituted tryptophan derivatives
AU763670B2 (en) New 2,3-methano-amino acid compounds, a process for their preparation and pharmaceutical compositions containing them
EP1370526B1 (en) Diamides which inhibit tryptase and factor xa activity
US5420283A (en) Resolution of (R)-2-benzylsuccinic acid 4-[4-(N-t-butoxycarbonylmethylamino)-piperidine] amide
JPH0848664A (ja) 新規なグアニジノ安息香酸エステル誘導体
Cesar et al. Use of 3, 5-disubstituted 1, 2, 4-triazoles for the synthesis of peptidomimetics
Obreza et al. Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitors
JP2004523560A5 (enExample)

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued